Get all premium features to the best stock analysis tool

Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification

Backed by an Exclusive 20-Year McMaster University License, Triera Targets High-Priority Infectious Disease and Oncology Detection Markets Across Canada, the United States, and Europe GUELPH, ON / ACCESS Newswire / March 25, 2026 / Zentek Ltd. (TSXV:ZEN)(NASDAQ:ZTEK) ("Zentek" or the "Company") announces that its wholly-owned subsidiary, Triera Biosciences Ltd.

Zentek Ltd. Receives Favorable Judgment in Long-Standing Litigation

Ontario Superior Court Dismisses Claims Originally Exceeding $6 Million Against Zentek GUELPH, ON / ACCESS Newswire / March 13, 2026 / Zentek Ltd. (TSXV:ZEN)(NASDAQ:ZTEK) ("Zentek" or the "Company") announces that the Ontario Superior Court of Justice (Commercial List) has issued its Reasons for Judgment dated March 12, 2026, in the companion actions Eveleigh et al.

Zentek Provides PDAC 2026 Update - Government and First Nations Engagement

Company advances Albany Graphite relationships across federal, provincial, and community levels GUELPH, ON / ACCESS Newswire / March 9, 2026 / Zentek Ltd. (TSXV:ZEN)(NASDAQ:ZTEK) ("Zentek" or the "Company") is pleased to provide shareholders with an update on its activities at and around the PDAC 2026 Convention held in Toronto from March 1-4, 2026.

Zentek Announces Pilot Evaluation Program with Quality Filters Inc.

GUELPH, ON / ACCESS Newswire / March 4, 2026 / Zentek Ltd. ("Zentek" or the "Company") (TSXV:ZEN)(NASDAQ:ZTEK) is pleased to announce the initiation of a pilot evaluation program with Quality Filters Inc. ("Quality"), a U.S.-based manufacturer of heating, ventilation and air conditioning ("HVAC") and industrial air filtration products, to assess the integration of Zentek's proprietary air filtration media technology into Quality's commercial product lines.